NC
Nikhil Chopra
About Nikhil Chopra
Data last updated:
Nikhil Chopra is a Director at Siddharth Civicon Private Limited (since 2018), Additional Director at Shri Vasudev Diagnostic Private Limited (since 2025) and Director at Gwalior Navodaya Pharma Solutions Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹62.87 Cr; the largest is Siddharth Civicon Private Limited at ₹47.39 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Oct 2018 | 2016 | ₹47.39 Cr (FY 2024) | Active | |
| Additional Director | 27 May 2025 | 2016 | ₹15.48 Cr (FY 2025) | Active | |
| Director | 24 Apr 2025 | 2025 | Active | ||
| Director | 20 Jun 2024 | 2024 | Active |
Board colleagues of Nikhil Chopra
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nikhil Chopra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nikhil Chopra
Nikhil Chopra currently holds 4 directorships: Siddharth Civicon Private Limited (Director, since 01 Oct 2018, revenue ₹47.39 Cr (FY 2024)); Shri Vasudev Diagnostic Private Limited (Additional Director, since 27 May 2025, revenue ₹15.48 Cr (FY 2025)); Gwalior Navodaya Pharma Solutions Private Limited (Director, since 24 Apr 2025); Gwalior Navodaya Healthcare Private Limited (Director, since 20 Jun 2024).
Nikhil Chopra was first appointed on 01 Oct 2018 as Director at Siddharth Civicon Private Limited. The most recent appointment on record is 27 May 2025 at Shri Vasudev Diagnostic Private Limited.
The 2 current companies of Nikhil Chopra that report revenue have a combined latest revenue of ₹62.87 Cr: Siddharth Civicon Private Limited ₹47.39 Cr (FY 2024); Shri Vasudev Diagnostic Private Limited ₹15.48 Cr (FY 2025).
The current boards of Nikhil Chopra's companies include Arti Sharma (Siddharth Civicon Private Limited), Deepak Yadav (Siddharth Civicon Private Limited), Manoj Gulati (Siddharth Civicon Private Limited), Neha Bhargava (Siddharth Civicon Private Limited), Raj Kishori Prajapati (Siddharth Civicon Private Limited), Rajiv Gupta (Siddharth Civicon Private Limited), among others.